EPA:ALMIB - Euronext Paris - Matif - FR0011051598 - Common Stock - Currency: EUR
EPA:ALMIB (4/30/2025, 7:00:00 PM)
1.267
+0 (+0.16%)
The current stock price of ALMIB.PA is 1.267 EUR. In the past month the price increased by 35.65%. In the past year, price increased by 175.44%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
DSFIR.AS | DSM-FIRMENICH AG | 101.4 | 25.32B | ||
6D81.DE | DUPONT DE NEMOURS INC | 16.07 | 24.08B | ||
BRG.OL | BORREGAARD ASA | 21.65 | 17.84B | ||
SY1.DE | SYMRISE AG | 29.69 | 14.19B | ||
ELK.OL | ELKEM ASA | 23.33 | 11.64B | ||
1COV.DE | COVESTRO AG | N/A | 11.11B | ||
AKZA.AS | AKZO NOBEL N.V. | 18.16 | 9.49B | ||
EVK.DE | EVONIK INDUSTRIES AG | 25 | 9.20B | ||
SYENS.BR | SYENSQO SA | 11.88 | 6.54B | ||
AMC.DE | ALBEMARLE CORP | N/A | 6.06B | ||
AKE.PA | ARKEMA | 8.12 | 5.07B | ||
WCH.DE | WACKER CHEMIE AG | 13.64 | 3.44B |
Amoéba SA.is a lyonnaise greentech company based on chassieu whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. The company is headquartered in Chassieu, Auvergne-Rhone-Alpes. The company went IPO on 2015-07-10. The firm specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The firm's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The firm is engaged in various technical, commercial, industrial and investment partnerships.
AMOEBA SAS
38 avenue des Freres Montgolfier
Chassieu AUVERGNE-RHONE-ALPES FR
Employees: 22
Company Website: https://amoeba-nature.com/en/
Investor Relations: http://www.amoeba-biocide.com/en/regulatories-information-and-financial-documents
Phone: 33426691600
The current stock price of ALMIB.PA is 1.267 EUR. The price increased by 0.16% in the last trading session.
The exchange symbol of AMOEBA SAS is ALMIB and it is listed on the Euronext Paris - Matif exchange.
ALMIB.PA stock is listed on the Euronext Paris - Matif exchange.
9 analysts have analysed ALMIB.PA and the average price target is 1.67 EUR. This implies a price increase of 32.03% is expected in the next year compared to the current price of 1.267. Check the AMOEBA SAS stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AMOEBA SAS (ALMIB.PA) has a market capitalization of 62.92M EUR. This makes ALMIB.PA a Micro Cap stock.
AMOEBA SAS (ALMIB.PA) currently has 22 employees.
AMOEBA SAS (ALMIB.PA) has a support level at 0.98. Check the full technical report for a detailed analysis of ALMIB.PA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALMIB.PA does not pay a dividend.
AMOEBA SAS (ALMIB.PA) will report earnings on 2025-10-01.
AMOEBA SAS (ALMIB.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.28).
ChartMill assigns a technical rating of 10 / 10 to ALMIB.PA. When comparing the yearly performance of all stocks, ALMIB.PA is one of the better performing stocks in the market, outperforming 99.07% of all stocks.
Over the last trailing twelve months ALMIB.PA reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS decreased by -75.4% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -220.37% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 87% to ALMIB.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.